Mechanisms of liver fibrosis associated with experimental fasciola hepatica infection: Roles of Fas2 proteinase and hepatic stellate cell activation

Journal of Parasitology

Volumn 97, Issue 1, 2011, Pages 82-87

  Marcos, Luis A ^a,b   Terashima, Angélica ^a,b   Yi, Pedro ^a,c   Andrade, Roy ^a,c   Cubero, Francisco J ^a,d   Albanis, Efsevia ^a,d   Gotuzzo, Eduardo ^a,b   Espinoza, Jose R ^a,c   Friedman, Scott L ^a,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CYSTEINE PROTEINASE; FAS ANTIGEN; FAS2 ANTIGEN; GELATINASE A; MESSENGER RNA; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ACTIN; COLLAGEN; FAS2 ANTIGEN, FASCIOLA HEPATICA; PARASITE ANTIGEN;

ANTIGEN; CELL ORGANELLE; ENZYME ACTIVITY; EXPERIMENTAL STUDY; FLATWORM; FUNCTIONAL MORPHOLOGY; GENE EXPRESSION; GENETIC ANALYSIS; INFECTIOUS DISEASE; INHIBITION; INHIBITOR; NUMERICAL MODEL; POLYMERASE CHAIN REACTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FASCIOLA HEPATICA; FASCIOLIASIS; FIBROGENESIS; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LIVER BIOPSY; LIVER FIBROSIS; MALE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; CELL LINE; DISEASE MODEL; ENZYMOLOGY; GENETICS; HUMAN; LIVER CIRRHOSIS; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; FASCIOLA HEPATICA; RATTUS;

ACTINS; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, HELMINTH; CELL LINE; COLLAGEN; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; FASCIOLA HEPATICA; FASCIOLIASIS; GENE EXPRESSION; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MALE; RATS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 79953807849     PISSN: 00223395     EISSN: 19372345     Source Type: Journal    
DOI: 10.1645/GE-2420.1     Document Type: Article

References (45)

1. ALBANIS, E., AND S. L. FRIEDMAN. 2001. Hepatic fibrosis. Pathogenesis and principles of therapy. Clinics in Liver Disease 5: 315-334. (Pubitemid 32472561)
2. ALMENDRAS-JARAMILLO M, J. RIVERA-MEDINA, J. SEIJAS-MOGROVEJO, AND K. ALMENDRAS JARAMILLO. 1997. Hepatic fascioliasis in children: Uncommon clinical manifestations. Arquivos de Gastroenterologia 34: 241-247. (Pubitemid 28144193)
3. BEDOSSA, P., AND T. POYNARD. 1996. The METAVIR cooperative study group: An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24: 289-293. (Pubitemid 26260021)
4. BERASAIN, P., F. GONI, S. MCGONIGLE, A. DOWD, J. P. DALTON, B. FRANGIONE, AND C. CARMONA. 1997. Proteinases secreted by Fasciola hepatica degrade extracellular matrix and basement membrane components. Journal of Parasitology 83: 1-5. (Pubitemid 27172236)
5. BLANCAS, G., A. TERASHIMA, C.MAGUINA, L. VERA, H. ALVAREZ, AND R. TELLO. 2004. Fasciolosis humana y compromiso gastrointestinal: Estudio de 277 Pacientes en el Hospital Nacional Cayetano Heredia. 1970-2002. Revista de Gastroenterologia del Peru 24: 143-157.
6. CAMPBELL, A. J., M. SHEERS, R. J. MOORE, S. R. EDWARDS, AND P. E. MONTAGUE. 1981. Proline biosynthesis by Fasciola hepatica at different developmental stages in vivo and vitro. Molecular and Biochemical Parasitology 3: 91-101.
7. CORDOVA, M., P. HERRERA, L. NOPO, J. BELLATIN, C. NAQUIRA, H. GUERRA, AND J. R. ESPINOZA. 1997. Fasciola hepatica cysteine proteinases: Immunodominant antigens in human fascioliasis. American Journal of Tropical Medicine and Hygiene 57: 660-666. (Pubitemid 28049380)
8. DIXIT, A. K., P. DIXIT, AND R. L. SHARMA. 2008. Immunodiagnostic/ protective role of cathepsin L cysteine proteinases secreted by Fasciola species. Veterinary Parasitology 4: 177-184.
9. DOOLEY, S., B. DELVOUX, B. LAHME, K.MANGASSER-STEPHAN, AND A. M. GRESSNER. 2000. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 31: 1094-1106. (Pubitemid 30233234)
10. EL-SHAZLY, A. M., M. SOLIMAN, A. GABR, A. N. HASEEB, A. T. MORSY, M. A. ARAFA, AND T. A. MORSY. 2001. Clinico-epidemiological study of human fascioliasis in an endemic focus in Dakahlia Governorate, Egypt. Journal of the Egyptian Society of Parasitology 31: 725-736.
11. -, H. A. EL-NAHAS, M. E. SOLIMAN, A. A. ABDEL-MAGEED, S. ELGHARABAWY, A. T. MORSY, AND M. M. HAMZA. 2005. Cholestasis in human fascioliasis in Dakahlia Governorate, Egypt. Journal of the Egyptian Society of Parasitology 35: 83-94.
12. ESPINOZA, J. R., V. MACo, L. A. MARCOS, S. SAEZ, V. NEYRA, A. TERASHIMA, F. SAMALVIDES, E.GOTUZZO, E.CHAVARRI, C.HUAMAN ET AL. 2007. Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. American Journal of Tropical Medicine and Hygiene 76: 977-982. (Pubitemid 351627690)
13. FRIEDMAN, S. L. 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. Journal of Biological Chemistry 275: 2247-2250. (Pubitemid 30081976)
14. -. 2004. Mechanisms of hepatic fibrosis and therapeutic implications. Nature Clinical Practice Gastroenterology & Hepatology 1: 98-105.
15. -. 2008. Hepatic stellate cells: Protean, multifunctional and enigmatic cells of liver. Physical Review 88: 125-172.
16. HEREDIA, D., J. M. BORDAS, F.MONDELO, AND J. RODES. 1984. Gallbladder fascioliasis in a patient with liver cirrhosis. Medicina Clinica (Barc) 82: 768-770.
17. IREDALE, J. P. 2001. Stellate cell behavior during resolution of liver injury. Seminars in Liver Disease 21: 427-436. (Pubitemid 32923770)
18. KATZ, N., A. CHAVEZ, AND J. PELLEGRINO. 1972. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Revista do Instituto de Medicina Tropical de São Paulo 14: 397-402.
19. LUMBRERAS, H., R. CANTELLA, AND R. BURGA. 1962. Acerca de un procedimiento de sedimentación rápida para investigar huevos de Fasciola hepatica en las heces, su evaluación y uso en el campo. Revista Medica Peruana 31: 167-174.
20. MARCOS, L. A., A. BUSSALLEU, A. TERASHIMA, AND J. R. ESPINOZA. 2009. Detection of antibodies against Fasciola hepatica in cirrhotic patients from Peru. Journal of Helminthology 83: 23-26.
21. -, V. MACo, A. TERASHIMA, F. SAMALVIDES, AND E. GOTUZZO. 2002. Características Clínicas de la infección crónica por Fasciola hepatica en niños. Revista de Gastroenterologia del Peru 22: 228-233.
22. -, -, M. CASTILLO, A. TERASHIMA, R. ZERPA, AND E. GOTUZZO. 2005. Report of cases of human fascioliosis in the Specialized Childrens Health Institute, Lima, Peru (1988-2003). Revista de Gastroenterologia del Peru 25: 198-205.
23. -, M. TAGLE, A. TERASHIMA, A. BUSSALLEU, C. RAMIREZ, C. CARRASCO, L. VALDEZ, J. HUERTA-MERCADO, D. O. FREEDMAN, J. M. VINETZ ET AL. 2008. Natural history, clinico-radiologic correlates and response to triclabendazole in acute massive fascioliasis. American Journal of Tropical Medicine and Hygiene 78: 222-227. (Pubitemid 351844554)
24. -, AND A. TERASHIMA. 2007. Update on human fascioliasis in Peru: Diagnosis, treatment and clinical classification proposal. Neotropical Helminthology 1: 85-103.
25. -, A. TERASHIMA, AND E. GOTUZZO. 2008. Update on hepatobiliary flukes: Fascioliasis, opisthorchiasis and clonorchiasis. Current Opinion in Infectious Diseases 21: 523-530.
26. -, -, G. LEGUIA, M. CANALES, J.R. ESPINOZA, AND E. GOTUZZO. 2007. Fasciola hepatica infection in Peru: An emergent disease. Revista de Gastroenterologia del Peru 27: 389-396.
27. -, P. YI, A. MACHICADO, R. ANDRADE, F. SAMALVIDES, J. SÁNCHEZ, AND A. TERASHIMA. 2007. Hepatic fibrosis and Fasciola hepatica infection in cattle. Journal of Helminthology 25: 1-6.
28. MARK, L. G., AND H. ISSEROFF. 1983. Levels of type I and type III collagen in the bile duct of rats infected with Fasciola hepatica. Molecular and Biochemical Parasitology 8: 253-262. (Pubitemid 13040112)
29. MCCRUDDEN, R., AND J. P. IREDALE. 2000. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. Histolology and Histopathology 15: 1159-1168.
30. NILSSON, M., T. DAHLMAN, B.WESTERMARK, AND K. WESTERMARK. 1995. Transforming growth factor-beta promotes epidermal growth factorinduced thyroid cell migration and follicle neoformation in collagen gel separable from cell proliferation. Experimental Cell Research 220: 257-265.
31. PARKINSON, M., S. M. ONEILL, AND J. P. DALTON. 2007. Endemic human fasciolosis in the Bolivian Altiplano. Epidemiology and Infection 135: 669-674. (Pubitemid 46647405)
32. PEREZ, J., J. MARTIN DE LAS MULAS, L. CARRASCO, P.N. GUTIERREZ, M. S. MARTINEZ-CRUZ, AND A. MARTINEZ-MORENO. 1999. Pathological and immunohistochemical study of the liver and hepatic lymph nodes in goats infected with one or more doses of Fasciola hepatica. Journal of Comparative Pathology 120: 199-210. (Pubitemid 29082005)
33. PHIRI, A. M., I. K. PHIRI, C. S. SIKASUNGE, M. CHEMBENSOFU, AND J. MONRAD. 2006. Comparative fluke burden and pathology in condemned and non-condemned cattle livers from selected abattoirs in Zambia. Onderstepoort Journal of Veterinary Research 73: 275-281. (Pubitemid 46119760)
34. PINZANI, M., S.MILANI, C.GRAPPONE, F. L.WEBER, JR., P. GENTILINI, AND H. E. ABBOUD. 1994. Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology 19: 701-707. (Pubitemid 24066902)
35. SANCHEZ-SOSA, S., S. ROJAS-ORTEGA, G. REED-SAN ROMAN, AND M. A. TORRES-SANTANA. 2000. Massive hepatobiliary fascioliasis. Revista de Gastroenterologia de Mexico 65: 179-183.
36. SCHUPPAN, D., M. RUEHL, R. SOMASUNDARAM, AND E. G. HAHN. 2001. Matrix as a modulator of hepatic fibrogenesis. Seminars in Liver Disease 21: 351-372. (Pubitemid 32923765)
37. SCHNUR, J., P. NAGY, A. SEBESTYEN, Z. SCHAFF, AND S. S. THORGEIRSSON. 1999. Chemical hepatocarcinogenesis in transgenic mice overexpressing mature TGF beta-1 in liver. European Journal of Cancer 35: 1842-1845. (Pubitemid 29512317)
38. SHIRAI, W., T. SATO, H. SHIBUYA, K. NAITO, AND A. TSUKISE. 2006. Anatomicopathological study of vascular and biliary systems using cast samples of Fasciola-infected bovine livers. Journal of Veterinary Medicine Series -A. Physiology Pathology Clinical Medicine 53: 239-245. (Pubitemid 43943719)
39. STACK, C. M., C. R. CAFFREY, S. M. DONNELLY, A. SESHAADRI, J. LOWTHER, J. F. TORT, P. R. COLLINS, M. W. ROBINSON, W. XU, J. H. MCKERROW ET AL. 2008. Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica. Journal of Biological Chemistry 283: 9896-9908.
40. STOLZ, D. B., AND G. K.MICHALOPOULOS. 1998. Differential modulation of hepatocyte growth factor-stimulated motility by transforming growth factor beta1 on rat liver epithelial cells in vitro. Journal of Cellular Physiology 175: 30-40. (Pubitemid 28101969)
41. TIMOTEO, O., V. MACo, JR., R. MACo, V. NEYRA, P. J. YI, G. LEQUÍA, AND J. R. ESPINOZA. 2005. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological findings. Veterinary Immunology and Immunopathology 106: 77-86. (Pubitemid 40723631)
42. VIGNOLES, P., L. FAVENNEC, D. RONDELAUD, AND G. DREYFUSS. 2003. The experimental production of Fasciola hepatica metacercariae from three aquatic populations of Galba truncatula. Journal of Helminthology 77: 275-277. (Pubitemid 36975536)
43. VITOVEC, J. 1974. Hepatocellular carcinoma in cattle and its relationship to biliary cirrhosis of fasciolar origin. Veterinary Pathology 11: 548-557.
44. WOLF-SPENGLER, M. L., AND H. ISSEROFF. 1983. Fascioliasis: Bile duct collagen induced by proline from the worm. Journal of Parasitology 69: 290-294. (Pubitemid 13073378)
45. XU, L., A. HUI, E.ALBANIS, M. J.ARTHUR, S. M. OBYRNE, W. S. BLANER, P. MUKHERJEE, S. L. FRIEDMAN, AND F. ENG. 2005. Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis. Gut 54: 142-151. (Pubitemid 40007234)